Panel Name: IKC - SynbiCITE Phase 2
Date of Panel: 27 February 2018
Panel Contact: Rendell, Ben
Dixon-Hardy, Dr J | University of Leeds | Panel Chairperson |
Beniston, Dr L | BBSRC | Observer |
Parkin, Mr J | BBSRC | Observer |
Davis, Dr AM | AstraZeneca UK Limited | |
Good, Dr T | National Science Foundation | |
Macnaghten, Professor P | Wageningen University | |
Warren, Professor MJ | Quadram Institute Bioscience | |
Rendell, Ben | Engineering and Physical Sciences Research Council | Panel Contact |
Funding rates may change over time until all decisions are finalised
|
Standard | 1 | 0 | 0 | 0 |
100
|
Including: |
Main List |
1 |
0 |
0 |
0 |
100 |
Please click on relevant Funding Priority List for a full rank ordered list.
|
Funding rates may change over time until all decisions are finalised
|
Standard | 3,058,262 | 0 | 0 | 0 |
100
|
Including: |
Main List |
3,058,262 |
0 |
0 |
0 |
100 |
Please click on relevant Funding Priority List for a full rank ordered list.
|